StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Skinvisible's operating cash flow for the twelve months ending Jun 30, 2026 was $3.84K. For fiscal 2025 it was -$38.41K. The highest annual figure on record is $374.61K in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$38.41K–
FY2024Dec 31, 2024-$69.83K–
FY2023Dec 31, 2023-$77.16K-270.8%
FY2022Dec 31, 2022$45.17K-87.9%
FY2021Dec 31, 2021$374.61K+718.5%
FY2020Dec 31, 2020$45.77K–
FY2019Dec 31, 2019-$128.21K–
FY2018Dec 31, 2018-$34.33K–
FY2017Dec 31, 2017-$13.88K–
FY2016Dec 31, 2016-$244.38K–
FY2015Dec 31, 2015-$852.74K–
FY2014Dec 31, 2014-$1.17M–
FY2013Dec 31, 2013-$751.65K–
FY2012Dec 31, 2012-$538.90K–
FY2011Dec 31, 2011-$192.46K-1210.6%
FY2010Dec 31, 2010$17.33K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.16K–
Q1 FY2026Mar 31, 2026-$822–
Q4 FY2025Dec 31, 2025$1.98K–
Q3 FY2025Sep 30, 2025$524–
Q2 FY2025Jun 30, 2025-$9.19K–
Q1 FY2025Mar 31, 2025-$31.72K–
Q4 FY2024Dec 31, 2024-$16.91K–
Q3 FY2024Sep 30, 2024-$12.54K–
Q2 FY2024Jun 30, 2024-$28.09K–
Q1 FY2024Mar 31, 2024-$12.29K–
Q4 FY2023Dec 31, 2023-$3.84K–
Q3 FY2023Sep 30, 2023-$4.82K–
Q2 FY2023Jun 30, 2023-$16.78K-110.9%
Q1 FY2023Mar 31, 2023-$51.72K-204.0%
Q4 FY2022Dec 31, 2022-$45.51K-124.4%
Q3 FY2022Sep 30, 2022-$32.92K–
Q4 FY2021Dec 31, 2021$153.81K+409.7%
Q3 FY2021Sep 30, 2021$49.75K–
Q2 FY2021Jun 30, 2021$186.71K+256.9%
Q1 FY2021Mar 31, 2021-$15.66K–
Q4 FY2020Dec 31, 2020$30.18K–
Q3 FY2020Sep 30, 2020-$20.88K-381.1%
Q2 FY2020Jun 30, 2020$52.31K–
Q1 FY2020Mar 31, 2020-$15.85K–
Q4 FY2019Dec 31, 2019-$86.24K–
Q3 FY2019Sep 30, 2019$7.43K-52.9%
Q2 FY2019Jun 30, 2019-$3.45K–
Q1 FY2019Mar 31, 2019-$45.95K-286.5%
Q4 FY2018Dec 31, 2018-$44.19K-138.6%
Q3 FY2018Sep 30, 2018$15.77K–
Q2 FY2018Jun 30, 2018-$30.54K–
Q1 FY2018Mar 31, 2018$24.64K–
Q4 FY2017Dec 31, 2017$114.47K–
Q3 FY2017Sep 30, 2017-$74–
Q2 FY2017Jun 30, 2017-$100.92K–
Q1 FY2017Mar 31, 2017-$27.34K–
Q4 FY2016Dec 31, 2016-$108.78K–
Q3 FY2016Sep 30, 2016-$43.35K–
Q2 FY2016Jun 30, 2016-$14.75K–

More Skinvisible figures

See a number that looks wrong?